243 related articles for article (PubMed ID: 28402164)
1. HiJAKing the epigenome in leukemia and lymphoma.
Drennan AC; Rui L
Leuk Lymphoma; 2017 Nov; 58(11):2540-2547. PubMed ID: 28402164
[TBL] [Abstract][Full Text] [Related]
2. TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.
Pike KA; Tremblay ML
Cytokine; 2016 Jun; 82():52-7. PubMed ID: 26817397
[TBL] [Abstract][Full Text] [Related]
3. JAK/STAT signaling in hematological malignancies.
Vainchenker W; Constantinescu SN
Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.
Sharma ND; Nickl CK; Kang H; Ornatowski W; Brown R; Ness SA; Loh ML; Mullighan CG; Winter SS; Hunger SP; Cannon JL; Matlawska-Wasowska K
Cancer Sci; 2019 Jun; 110(6):1931-1946. PubMed ID: 30974024
[TBL] [Abstract][Full Text] [Related]
5. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.
Venugopal S; Bar-Natan M; Mascarenhas JO
Blood Rev; 2020 Mar; 40():100634. PubMed ID: 31677846
[TBL] [Abstract][Full Text] [Related]
6. Janus kinase deregulation in leukemia and lymphoma.
Chen E; Staudt LM; Green AR
Immunity; 2012 Apr; 36(4):529-41. PubMed ID: 22520846
[TBL] [Abstract][Full Text] [Related]
7. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
[TBL] [Abstract][Full Text] [Related]
8. The JAK-STAT pathway: a therapeutic target in hematological malignancies.
Ferrajoli A; Faderl S; Ravandi F; Estrov Z
Curr Cancer Drug Targets; 2006 Dec; 6(8):671-9. PubMed ID: 17168672
[TBL] [Abstract][Full Text] [Related]
9. JAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny.
Cokic VP; Bhattacharya B; Beleslin-Cokic BB; Noguchi CT; Puri RK; Schechter AN
J Transl Med; 2012 Jun; 10():116. PubMed ID: 22676255
[TBL] [Abstract][Full Text] [Related]
10. Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling.
Chaimowitz NS; Forbes LR
Curr Opin Pediatr; 2019 Dec; 31(6):843-850. PubMed ID: 31693596
[TBL] [Abstract][Full Text] [Related]
11. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
Butterbach K; Beckmann L; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Boffetta P; Brennan P; Nieters A
Br J Haematol; 2011 May; 153(3):318-33. PubMed ID: 21418178
[TBL] [Abstract][Full Text] [Related]
12. Mast cell homeostasis and the JAK-STAT pathway.
Morales JK; Falanga YT; Depcrynski A; Fernando J; Ryan JJ
Genes Immun; 2010 Dec; 11(8):599-608. PubMed ID: 20535135
[TBL] [Abstract][Full Text] [Related]
13. STAT3 inhibitors: finding a home in lymphoma and leukemia.
Munoz J; Dhillon N; Janku F; Watowich SS; Hong DS
Oncologist; 2014 May; 19(5):536-44. PubMed ID: 24705981
[TBL] [Abstract][Full Text] [Related]
14. Inteferons pen the JAK-STAT pathway.
Schindler C; Plumlee C
Semin Cell Dev Biol; 2008 Aug; 19(4):311-8. PubMed ID: 18765289
[TBL] [Abstract][Full Text] [Related]
15. JAK/STAT: Why choose a classical or an alternative pathway when you can have both?
Puigdevall L; Michiels C; Stewardson C; Dumoutier L
J Cell Mol Med; 2022 Apr; 26(7):1865-1875. PubMed ID: 35238133
[TBL] [Abstract][Full Text] [Related]
16. Regulation of T cell homeostasis by JAKs and STATs.
Ross JA; Nagy ZS; Cheng H; Stepkowski SM; Kirken RA
Arch Immunol Ther Exp (Warsz); 2007; 55(4):231-45. PubMed ID: 17659375
[TBL] [Abstract][Full Text] [Related]
17. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases.
Hosseini A; Gharibi T; Marofi F; Javadian M; Babaloo Z; Baradaran B
J Cell Physiol; 2020 Sep; 235(9):5903-5924. PubMed ID: 32072644
[TBL] [Abstract][Full Text] [Related]
18. Organogenesis and tumorigenesis: insight from the JAK/STAT pathway in the Drosophila eye.
Wang YH; Huang ML
Dev Dyn; 2010 Oct; 239(10):2522-33. PubMed ID: 20737505
[TBL] [Abstract][Full Text] [Related]
19. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
20. The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.
Cai B; Cai JP; Luo YL; Chen C; Zhang S
Inflammation; 2015 Aug; 38(4):1599-608. PubMed ID: 25676437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
